Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kirsten L. Wahlstrøm, Sarah Ekeloef, Ismail Gögenur & Anna-Marie B. Münster. (2023) Myocardial injury after non-cardiac surgery and per operative fibrin metabolism in patients undergoing hip-fracture surgery: an observational study. Scandinavian Journal of Clinical and Laboratory Investigation 83:5, pages 299-308.
Read now
Read now
Björn Wiman. (1999) Predictive value of fibrinolytic factors in coronary heart disease. Scandinavian Journal of Clinical and Laboratory Investigation 59:sup230, pages 23-31.
Read now
Read now
A. Nordenhem & B. Wiman. (1997) Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene. Scandinavian Journal of Clinical and Laboratory Investigation 57:5, pages 453-461.
Read now
Read now
. (1996) Proceedings Dissertations. Acta Orthopaedica Scandinavica 67:sup270, pages 1-65.
Read now
Read now
Margareta Hedstrom, Per-Anders Flordal, Torbjorn Ahl, Jan Svensson & Nils Dalen. (1996) Autologous blood transfusion in hip replacement: No effect on blood loss but less increase of plasminogen activator inhibitor in a randomized series of 80 patients. Acta Orthopaedica Scandinavica 67:4, pages 317-320.
Read now
Read now
Articles from other publishers (44)
Kirsten L. Wahlstrøm, Sarah Ekeloef, Johannes J. Sidelmann, Ismail Gögenur & Anna-Marie B. Münster. (2022) Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial. Blood Coagulation & Fibrinolysis 33:1, pages 25-33.
Crossref
Crossref
Johannes J. Sidelmann, Jørgen B. Gram, Anne C.M. Godtfredsen, Jens J. Thorn, Janne Ingerslev & Else M. Pinholt. (2020) Orthognathic Surgery-Induced Fibrinolytic Shutdown Is Amplified by Tranexamic Acid. Journal of Oral and Maxillofacial Surgery 78:7, pages 1183-1189.
Crossref
Crossref
Rodrigo Ribeiro Pinho Rodarte, João Antônio Matheus Guimarães, José Sérgio Franco, Lorran Fonseca, Vilker Nascimento, José Paulo Gabbi Aramburu & João Mauricio Barretto. (2019) Revisão sistemática da profilaxia para tromboembolismo venoso após artroplastia do joelho: enoxaparina versus rivaroxabana.. Revista do Colégio Brasileiro de Cirurgiões 46:2.
Crossref
Crossref
Ari Zekcer, Ricardo Del Priori, Clauber Tieppo, Ricardo Soares da Silva & Nilson Roberto Severino. (2016) Topical vs. intravenous administration of tranexamic acid in knee arthroplasty and prevalence of deep venous thrombosis: a randomized clinical trial. Jornal Vascular Brasileiro 15:2, pages 120-125.
Crossref
Crossref
Taki Galanis & Geno J. Merli. 2013. Medical Management of the Surgical Patient. Medical Management of the Surgical Patient
234
251
.
Taki Galanis & Geno J. Merli. 2013. Perioperative Management of Patients with Rheumatic Disease. Perioperative Management of Patients with Rheumatic Disease
45
56
.
I. P. Akhtyamov, M. A. Kolesnikov, E. S. Shigaev, B. G. Ziatdinov, E. B. Gatina & O. S. Korotkova. (2012) A PRIMARY TEST OF COMBINED THROMBOPROPHYLAXIS AT LOWER EXTREMITIES ARTHROPLASTY: ASPECTS AND VARIANTS OF USAGE. Traumatology and Orthopedics of Russia 18:1, pages 98-103.
Crossref
Crossref
Luiz Eugênio Garcez Leme & Guilherme Turolla Sguizzatto. (2012) PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ORTHOPAEDIC SURGERY. Revista Brasileira de Ortopedia (English Edition) 47:6, pages 685-693.
Crossref
Crossref
Taki Galanis, Walter K. Kraft & Geno J. Merli. (2011) Prophylaxis for Deep Vein Thrombosis and Pulmonary Embolism in the Surgical Patient. Advances in Surgery 45:1, pages 361-390.
Crossref
Crossref
Geno J. Merli. 2010. Medical Management of the Surgical Patient. Medical Management of the Surgical Patient
248
268
.
John A. Heit. (2003) The Potential Role of Direct Thrombin Inhibitors in the Prevention and Treatment of Venous Thromboembolism. Chest 124:3, pages 40S-48S.
Crossref
Crossref
H. Arnesen, O.E. Dahl, T. Aspelin, I. Seljeflot, P. Kierulf & T. Lyberg. (2003) Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. Journal of Thrombosis and Haemostasis 1:5, pages 971-975.
Crossref
Crossref
William Macaulay, Geoffrey Westrich, Nigel Sharrock, Thomas P. Sculco, Peter H. Jhon, Margaret G.E. Peterson & Eduardo A. Salvati. (2002) Effect of Pneumatic Compression on Fibrinolysis After Total Hip Arthroplasty. Clinical Orthopaedics and Related Research 399, pages 168-176.
Crossref
Crossref
Joseph A Caprini, Juan I Arcelus & Jos?J Reyna. (2001) Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Seminars in Hematology 38, pages 12-19.
Crossref
Crossref
F. Bachmann. 2001. Fibrinolytics and Antifibrinolytics. Fibrinolytics and Antifibrinolytics
3
23
.
Helena Mångs, Guang-Chao Sui & Björn Wiman. (2000) PAI-1 stability: the role of histidine residues. FEBS Letters 475:3, pages 192-196.
Crossref
Crossref
Björn Wiman. (2000) THE FIBRINOLYTIC ENZYME SYSTEM. Hematology/Oncology Clinics of North America 14:2, pages 325-338.
Crossref
Crossref
Elisabeth Moor, Margareta Blombäck, Angela Silveira, Björn Wiman, Kerstin Cederlund, Lott Bergstrand, Torbjörn Ivert, Lars Rydén & Anders Hamsten. (2000) Haemostatic Function in Patients Undergoing Coronary Artery Bypass Grafting. Thrombosis Research 98:1, pages 39-49.
Crossref
Crossref
Lena Holmdahl. 2000. Peritoneal Surgery. Peritoneal Surgery
117
131
.
Geno J. Merli. (1999) DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM PROPHYLAXIS IN JOINT REPLACEMENT SURGERY. Rheumatic Disease Clinics of North America 25:3, pages 639-656.
Crossref
Crossref
G. Falk, G.-C. Sul, S. Schulman & B. Wiman. (1999) Detection of a new polymorphism in the PAI-1 gene located in the pro-peptide coding region. Fibrinolysis and Proteolysis 13:1, pages 26-30.
Crossref
Crossref
Jay R. Lieberman. 1999. Revision Total Hip Arthroplasty. Revision Total Hip Arthroplasty
401
417
.
C N Berry, C Lunven, I Lechaire, C Girardot & S E O'Connor. (2009) Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis. British Journal of Pharmacology 125:1, pages 29-34.
Crossref
Crossref
André Planes, Nicole Vochelle & Jean-Yves Darmon. (1998) Out-of-Hospital Prophylaxis With Low-Molecular-Weight Heparin in Hip Surgery. Chest 114:2, pages 125S-129S.
Crossref
Crossref
Brian A. Rosenfeld, Ngoc-Diep Nguyen, Ik Sung & Nauder Faraday. (1998) Neuroendocrine Stress Hormones Do Not Recreate the Postoperative Hypercoagulable State. Anesthesia & Analgesia 86:3, pages 640-645.
Crossref
Crossref
Y. López, J. A. Páramo, R. Montes, E. Rocha, J. R. Valentí & F. Pardo. (1997) Hemostatic markers in surgery: a different fibrinolyfic activity may be of pathophysiological significance in orthopedic versus abdominal surgery. International Journal of Clinical & Laboratory Research 27:2-4, pages 233-237.
Crossref
Crossref
G. Falk, M.T. Sartori, G.M. Patrassi, S. Vettore, A. Girolami & B. Wiman. (1997) Identification of an 18 basepair deletion in the PAI-1 gene promoter region in a family with thrombotic disease. Fibrinolysis and Proteolysis 11:5-6, pages 239-244.
Crossref
Crossref
H.R Williams & D.A Macdonald. (1997) Thromboprophylaxis in lower limb arthroplasty surgery: A review. Current Orthopaedics 11:1, pages 19-23.
Crossref
Crossref
André Planes, Nicole Vochelle, Jean-Yves Darmon, Michel Fagola, Michel Bellaud & Yann Huet. (1996) Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. The Lancet 348:9022, pages 224-228.
Crossref
Crossref
Bruce D. Spiess. 1996. Anesthesiology and the Cardiovascular Patient. Anesthesiology and the Cardiovascular Patient
111
121
.
Leon Poller, Jean M. Thomson, Peter K. MacCallum, David A. Nicholson, Frank J. Weighill & Jerry G. Lemon. (2016) Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity. Clinical and Applied Thrombosis/Hemostasis 1:4, pages 267-273.
Crossref
Crossref
Stephen C.L. Koh, H.L. Pua, Dicky H.B. Tay & S.S. Ratnam. (1995) The effects of gynaecological surgery on coagulation activation, fibrinolysis and fibrinolytic inhibitor in patients with and without ketorolac infusion. Thrombosis Research 79:5-6, pages 501-514.
Crossref
Crossref
R. Kätzel, B. Wiedemann, H. Keuper & L. Brethner. (1994) The effect of the anaesthesia procedure on intraoperative fibrinolysis activation and postoperative fibrinolytic shut-down. Fibrinolysis 8:5, pages 309-316.
Crossref
Crossref
J R Lieberman & W H Geerts. (1994) Prevention of venous thromboembolism after total hip and knee arthroplasty.. The Journal of Bone & Joint Surgery 76:8, pages 1239-1250.
Crossref
Crossref
Herbert K. F. Lau, Jerome M. Teitel, To Cheung, Sam K. P. Kung & M. Bernadette Garvey. (2006) Hypofibrinolysis in patients with hypercoagulability: The roles of urokinase and of plasminogen activator inhibitor. American Journal of Hematology 44:4, pages 260-265.
Crossref
Crossref
V. Arnman, L. Rymo & B. Risberg. (1993) Different fibrinolytic potential in cultured human adult and umbilical vein endothelial cells. Fibrinolysis 7:3, pages 165-170.
Crossref
Crossref
Geno J. Merli. (1993) Update: Deep vein thrombosis and pulmonary embolism prophylaxis in orthopedic surgery. Medical Clinics of North America 77:2, pages 397-411.
Crossref
Crossref
A. O. Aasen & L. Buø. 1993. Pathophysiology of Shock, Sepsis, and Organ Failure. Pathophysiology of Shock, Sepsis, and Organ Failure
36
45
.
Per Anders Flordal. 1993. Desmopressin in Bleeding Disorders. Desmopressin in Bleeding Disorders
135
145
.
C.K. Høgdall, E.V.S. Høgdall, L.N. Jørgensen & I. Clemmensen. (1992) Changes in plasma tetranectin following hip surgery with or without thrombotic complications. Thrombosis Research 67:4, pages 399-405.
Crossref
Crossref
Sally Dawson & Adriano Henney. (1992) The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 95:2-3, pages 105-117.
Crossref
Crossref
Björn Wiman & Anders Hamsten. (1991) Impaired fibrinolysis and risk of thromboembolism. Progress in Cardiovascular Diseases 34:3, pages 179-192.
Crossref
Crossref
Jens V. Sørensen, Michael R. Lassen, Lars C. Borris, Peter S. Jørgensen, Peter Schøtt, Stephanie Weber, Rosemary Murphy & Jeanine Walenga. (1990) Postoperative deep vein thrombosis and plasma levels of tissue plasminogen activator inhibitor. Thrombosis Research 60:3, pages 247-251.
Crossref
Crossref
Geno J. Merli. (1990) Prophylaxis for Deep Vein Thrombosis and Pulmonary Embolism in the Geriatric Patient Undergoing Surgery. Clinics in Geriatric Medicine 6:3, pages 531-542.
Crossref
Crossref